68Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate cancer patients: Diagnostic and predictive value for the biochemical response to surgery-Reference-Cited by-同舟云学术

68Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate cancer patients: Diagnostic and predictive value for the biochemical response to surgery

Published:2019-03 Issue:1095 Volume:92 Page:20180667
ISSN:0007-1285
Container-title:The British Journal of Radiology
language:en
Short-container-title:BJR

Author:

Nandurkar Rohan¹^ORCID,van leeuwen Pimmeke²³,Stricker Phillip²⁴,Woo Henry⁵,Kooner Rajdeep⁴,Yuen Carlo⁴,O'Neill Gordon⁴,Ende David⁴,Cusick Thomas²,Ho Bao⁶,Hickey Adam⁶,emmett Louise²⁶

Affiliation:

1. Faculty of Medicine, University of New South Wales Sydney, Sydney, NSW, Australia

2. Clinical Prostate Cancer Research, The Garvan Institute of Medical Research, Sydney, NSW, Australia

3. Department of Urology, Erasmus Medical Center, Rotterdam, Netherlands

4. Department of Urology, St Vincent’s Clinic, Sydney, NSW, Australia

5. Department of Urology, Sydney Adventist Hospital, Sydney, NSW, Australia

6. Department of Nuclear Medicine, St Vincent's Hospital Sydney, Sydney, NSW, Australia

Publisher

British Institute of Radiology

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

https://www.birpublications.org/doi/pdf/10.1259/bjr.20180667

Reference21 articles.

1. Postoperative early ultrasensitive prostate-specific antigen identifies patients at risk for biochemical recurrence in margin positive prostate cancers: a single-center study

2. Ultrasensitive Prostate Specific Antigen Assay Following Laparoscopic Radical Prostatectomy – An Outcome Measure for Defining the Learning Curve

3. Detectable Prostate Specific Antigen Between 60 and 120 Days Following Radical Prostatectomy for Prostate Cancer: Natural History and Prognostic Significance

4. Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy

5. ULTRASENSITIVE DETECTION OF PROSTATE SPECIFIC ANTIGEN IN THE FOLLOWUP OF 422 PATIENTS AFTER RADICAL PROSTATECTOMY

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using multiparametric Magnetic Resonance Imaging and Prostate Specific Membrane Antigen Positron Emission Tomography to detect and delineate the gross tumour volume of intraprostatic lesions – A systematic review and meta-analysis;Radiotherapy and Oncology;2024-03

2. The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature;European Urology Oncology;2024-02

3. Prognostic Value of PSMA PET/CT in Prostate Cancer;Seminars in Nuclear Medicine;2024-01

4. The Role of PSMA PET/CT and PET/MRI in the Initial Staging of Prostate Cancer;Advances in Clinical Medicine;2024

5. Application of targeted diagnosis of PSMA in the modality shift of prostate cancer diagnosis: a review;Frontiers in Oncology;2023-09-01